(Q44433569)

English

Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance

scientific article published on 5 September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Wai Man Wong

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Qing Gu

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Wei Hong Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Fiona Man-Yee Fung

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Douglas E Berg

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kam Chuen Lai

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Harry Hua-Xiang Xia

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Wayne H C Hu

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Chi Kuen Chan

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Annie On-On Chan

10

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Man-Fung Yuen

11

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Chee-Kin Hui

12

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Shiu Kum Lam

13

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Benjamin Chun-Yu Wong

14

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

5 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

882-889

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients.

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Prevalence of metronidazole-resistant Helicobacter pylori in dyspeptic patients.

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

A reliable cure for Helicobacter pylori infection?

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

An evaluation of invasive and non-invasive tests for the diagnosis of Helicobacter pylori infection in Chinese

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Regular review: treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

13C-urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in Chinese

1 reference

https://api.crossref.org/works/10.1086%2F377206

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44433569&oldid=2023267218"